Prof Mika Ala-Korpela: Systems Epidemiology and Causal Inference in the Omics Era
Location:Seminar Room 6, Westmead Hospital Education and Conference Centre (WECC)
Professor Mika Ala-Korpela, PhD in Physics | Docent in Biological NMR, Head: Systems Epidemiology, Baker Heart and Diabetes Institute
This presentation focuses on epidemiology in the current omics era, shows results from recent large-scale epidemiological and genetic studies and also discusses the ‘holy grail‘ of epidemiology – how to separate association from causation – in the light of biobanks and open omics data.
Examples of how to understand systemic drug effects, without performing a drug trial, will be discussed.
Date: Friday 1 June 2018
Time: 12pm – 1pm (light lunch will be served at 11:45am)
Venue: Seminar Room 6, Westmead Hospital Education and Conference Centre (WECC)
RSVP: [email protected] by 23 May 2018
Professor Ala-Korpela was granted a Distinguished Talent Visa to Australia in October 2017. He commenced work in Melbourne the Baker Heart and Diabetes Institute in January 2018 as the Head of a new Systems Epidemiology Laboratory.
He has held a Professorship at the Medical Faculty of University of Oulu (Finland) for 9 years and a Professorship in Computational Medicine at the Bristol Medical School, University of Bristol (UK) for 5 years.
He is an affiliate Senior Member of the UK Medical Research Council Integrative Epidemiology Unit, a large alliance of research excellence in systems epidemiology, at the University of Bristol.
Professor Ala-Korpela is an Associate Editor of the International Journal of Epidemiology. He has published 200 international peer-reviewed scientific papers, cited 7000 times with a steep upward trajectory.
Professor Ala-Korpela’s research focuses on lipoprotein and lipid metabolism, development and applications of multivariate data analysis methods for metabolic phenotyping and risk assessment, and development and utilisation of various omics technologies in clinical and systems epidemiology to study the aetiology of metabolic diseases.
He has 25 years of experience in biomedical research and has pioneered high-throughput applications of serum metabolomics in epidemiology and genetics.
Professor Ala-Korpela is gaining recognition as an advocate of large-scale collaborative research and replication studies in metabolomics research.